to assess the results of therapeutic advances in the treatment of small cell carcinoma of the lung ( sccl ) achieved during the past 15-year period at a single large institution , 508 patients treated between 1968 and 1982 were divided into two groups : 157 patients ( 66 in the category of limited-stage disease and 91 in the extensive-stage disease category ) treated with low-dose small-volume radiotherapy ( rt ) ( time dose fractionation [ tdf ] 49-66 ) and with cyclophosphamide alone or a copp program during the first period of 7 years ( 1968-1974 ) ;
C0010583
cyclophosphamide
C0056286
copp